• Crystal Bioscience Inc., of Emeryville, Calif., and Integral Molecular Inc., of Philadelphia, said they launched a research collaboration to generate panels of chicken monoclonal antibodies against undisclosed therapeutic G protein-coupled receptor and ion channel targets.